Definition
Components
-
Data Element ConceptPerson—cholesterol level
-
Object ClassPerson
-
PropertyCholesterol level
-
-
Value DomainTotal millimoles per litre N[N].N
Representation
This representation is based on the value domain for this data element, more information is available at " Total millimoles per litre N[N].N ".Data Type | Number |
---|---|
Format | N[N].N |
Maximum character length | 3 |
Value | Meaning | Start Date | End Date | |
---|---|---|---|---|
Supplementary Values | 99.9 | Not stated/inadequately described. |
Comments
Guide for use:
Measurement in mmol/L to 1 decimal place.
Record the absolute result of the total cholesterol measurement. When reporting, record whether or not the measurement of Cholesterol-total - measured was performed in a fasting specimen.
Origin:National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, Lipid Management Guidelines - 2001, MJA 2001; 175: S57-S88
National Health Priority Areas Report: Cardiovascular Health 1998. AIHW Cat. No. PHE 9. HEALTH and AIHW, Canberra.
The Royal College of Pathologists of Australasia web based Manual of Use and Interpretation of Pathology Tests
Comments:In settings where the monitoring of a person's health is ongoing and where a measure can change over time (such as general practice), the Service contact—service contact date, DDMMYYYY should be recorded.
High blood cholesterol is a key factor in heart, stroke and vascular disease, especially coronary heart disease.
Poor nutrition can be a contributing factor to heart, stroke and vascular disease as a population's level of saturated fat intake is the prime determinant of its level of blood cholesterol.
Large clinical trials have shown that people at highest risk of cardiovascular events (e.g. pre-existing ischaemic heart disease) will derive the greatest benefit from lipid lowering drugs. For this group of patients, the optimum threshold plasma lipid concentration for drug treatment is still a matter of research. In May 1999 the PBS threshold total cholesterol concentration, for subsidy of drug treatment, was reduced from 5.5 to 4.0 mmol/L. (Australian Medical Handbook).